Sara F. Zaman-Uz

Frankfurt Am Main, HE 60590, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A Prospective Analysis of the Burden of Multi-Drug-Resistant Pathogens in Acute Appendicitis and Their Implication for Clinical Management.

A Prospective Analysis of the Burden of Multi-Drug-Resistant Pathogens in Acute Appendicitis and Their Implication for Clinical Management.

Journal: Antibiotics (Basel, Switzerland)

Published: March 03, 2025

Usability Testing of a Digitized Interventional Prehabilitation Tool for Health Care Professionals and Patients Before Major Surgeries: Formative and Summative Evaluation.

Usability Testing of a Digitized Interventional Prehabilitation Tool for Health Care Professionals and Patients Before Major Surgeries: Formative and Summative Evaluation.

Journal: JMIR formative research

Published: April 14, 2024

Predictive value of a novel digital risk calculator to determine early patient outcomes after major surgery: a proof-of-concept pilot study.

Predictive value of a novel digital risk calculator to determine early patient outcomes after major surgery: a proof-of-concept pilot study.

Journal: Patient safety in surgery

Published: January 22, 2024

Validity, Accuracy, and Safety Assessment of an Aerobic Interval Training Using an App-Based Prehabilitation Program (PROTEGO MAXIMA Trial) Before Major Surgery: Prospective, Interventional Pilot Study.

Validity, Accuracy, and Safety Assessment of an Aerobic Interval Training Using an App-Based Prehabilitation Program (PROTEGO MAXIMA Trial) Before Major Surgery: Prospective, Interventional Pilot Study.

Journal: JMIR mHealth and uHealth

Published: December 08, 2023

A toolbox for a structured risk-based prehabilitation program in major surgical oncology.

A toolbox for a structured risk-based prehabilitation program in major surgical oncology.

Journal: Frontiers in surgery

Published: March 15, 2023

Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target.

Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target.

Journal: Cancer gene therapy

Published: February 06, 2023

The Diagnostic Efficacy of an App-based Diagnostic Health Care Application in the Emergency Room: eRadaR-Trial. A prospective, Double-blinded, Observational Study.

The Diagnostic Efficacy of an App-based Diagnostic Health Care Application in the Emergency Room: eRadaR-Trial. A prospective, Double-blinded, Observational Study.

Journal: Annals of surgery

Published: August 04, 2022

Study protocol for a prospective, double-blinded, observational study investigating the diagnostic accuracy of an app-based diagnostic health care application in an emergency room setting: the eRadaR trial.

Study protocol for a prospective, double-blinded, observational study investigating the diagnostic accuracy of an app-based diagnostic health care application in an emergency room setting: the eRadaR trial.

Journal: BMJ open

Published: January 09, 2021

BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis.

BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis.

Journal: Cancer letters

Published: June 06, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026